ENTITY
Acotec Scientific

Acotec Scientific (6669 HK)

57
Analysis
Health Care • China
Acotec Scientific is a medical technology company specializing in the research, development, and application of innovative solutions for vascular diseases. Its core products include drug-coated balloons (DCB) and percutaneous transluminal angioplasty (PTA) balloon catheters, such as AcoArt Orchid & Dhalia. The company was founded in 2008 and is headquartered in Beijing, China.
more
bullish•NetEase Cloud Music
•01 Aug 2021 10:04

ECM Weekly (1st August 2021) - Cloud Village, Li Auto HK, Asymchem, Acotec, Devyani, Del Monte PH

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
bullish•Acotec Scientific
•26 Jul 2021 10:32

Acotec (å…ˆē‘žč¾¾) Pre-IPO: Thoughts on Valuation

We provide our forecast and valuation for the company's two key products AcoArt Orchid & Dhalia, as well as AcoArt Tulip & Litos.

Logo
365 Views
Share
•19 Jul 2021 12:04

Shanghai HeartCare (åæƒēŽ®åŒ»ē–—) Pre-IPO: Thoughts on Valuation

We forecast the sales of HeartCare's four key products, namely Captor, Intracranial Catheter, LAA Occluder, and embolic coil, and also provide an...

Logo
638 Views
Share
bullish•Full Truck Alliance
•04 Jul 2021 10:21

ECM Weekly (4th July 2021) - Xpeng, Medbot, Medlive, Brii Bio, CTOS, LinkDoc, Devyani, Manycore

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
bullish•Acotec Scientific
•30 Jun 2021 11:08

Acotec (å…ˆē‘žč¾¾) Pre-IPO: Early Mover Advantage in Peripheral DCB

Acotec is early in the peripheral artery drug coated balloon device market with a dominant market share for above-the-knee stenosis. Having said...

Logo
557 Views
Share
x